Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 555, Issue 1-2 SPEC. ISS., 2004, Pages 65-80

  Kundu, Joydeb Kumar ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Activator protein 1 (AP 1); Apoptosis; Cell cycle regulation; Cellular signaling; Chemoprevention; Nuclear factor B (NF B); Resveratrol

Indexed keywords

ANTIOXIDANT; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RESVERATROL; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CYTOLOGY; DNA ADDUCT; DNA BINDING; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; HUMANS; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; STILBENES; TRANSCRIPTION FACTOR AP-1;

EUKARYOTA;

EID: 5144223780     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.05.019     Document Type: Review

References (106)

1. Y.-J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
2. World Cancer Research Fund/American Institute for Cancer Research Food, Nutrition and Prevention of Cancer: A Global Perspective, American Institute for Cancer Research Washington, DC, 1997.
3. E.J. Park, and J.M. Pezzuto Botanicals in cancer chemoprevention Cancer Metastasis Rev. 21 2002 231 255
4. Y.-J. Surh Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review Food. Chem. Toxicol. 40 2002 1091 1097
5. W. Dercks, and L.L. Creasy The significance of stilbene phytoalexins in the Plasmopara viticola-grapevine interaction Physiol. Mol. Plant Pathol. 34 1989 189 202
6. W. Dercks, and L.L. Creasy Influence of fosetyl-Al on phytoalexin accumulation in the Plasmopara viticola-grapevine interaction Physiol. Mol. Plant Pathol. 34 1989 203 213
7. J.-H. Jang, and Y.-J. Surh Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death Free Radic. Biol. Med. 34 2003 1100 1110
8. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
9. K.P.L. Bhat, D. Lantvit, K. Christov, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models Cancer Res. 61 2001 7456 7463
10. S. Banerjee, C. Bueso-Ramos, and B.B. Aggarwal Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9 Cancer Res. 62 2002 4945 4954
11. Z.G. Li, T. Hong, Y. Shimada, I. Komoto, A. Kawabe, Y. Ding, J. Kaganoi, Y. Hashimoto, and M. Imamura Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol Carcinogenesis 23 2002 1531 1536
12. (Min/+) mice J. Nutr. 134 2004 5 10
13. S.S. Hecht, P.M. Kenney, M. Wang, N. Trushin, S. Agarwal, A.V. Rao, and P. Upadhyaya Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice Cancer Lett. 137 1999 123 130
14. M. Jang, and J.M. Pezzuto Effects of resveratrol on 12-O- tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin Cancer Lett. 134 1998 81 89
15. 3 Free Radic. Biol. Med. 26 1999 1531 1537
16. J.G. Dubuisson, D.L. Dyess, and J.W. Gaubatz Resveratrol modulates human mammary epithelial cell O-acetyltransferase, sulfotransferase, and kinase activation of the heterocyclic amine carcinogen N-hydroxy-PhIP Cancer Lett. 182 2002 27 32
17. H.P. Ciolino, and G.C. Yeh Inhibition of aryl hydrocarbon-induced cytochrome P-4501A1 enzyme activity and CYP1A1 expression by resveratrol Mol. Pharmacol. 56 1999 760 767
18. A. Boyce, J. Doehmer, and N.J. Gooderham Phytoalexin resveratrol attenuates the mutagenicity of the heterocyclic amines 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 802 2004 217 223
19. R.F. Casper, M. Quesne, I.M. Rogers, T. Shirota, A. Jolivet, E. Milgrom, and J.F. Savouret Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity Mol. Pharmacol. 56 1999 784 790
20. J. Gusman, H. Malonne, and G. Atassi A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol Carcinogenesis 22 2001 1111 1117
21. Z.-H. Chen, Y.-J. Hurh, H.-K. Na, J.-H. Kim, Y.-J. Chun, D.-H. Kim, K.-S. Kang, M.-H. Cho, Y.-J. Surh, Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells, Carcinogenesis, in press.
22. L. Andrieux, S. Langouet, A. Fautrel, F. Ezan, J.A. Krauser, J.F. Savouret, F.P. Guengerich, G. Baffet, and A. Guillouzo Aryl hydrocarbon receptor activation and cytochrome P4501A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes Mol. Pharmacol. 65 2004 934 943
23. C. Gerhauser, K. Klimo, E. Heiss, I. Neumann, A. Gamal-Eldeen, J. Knauft, G.Y. Liu, S. Sitthimonchai, and N. Frank Mechanism-based in vitro screening of potential cancer chemopreventive agents Mutat. Res. 523-524 2003 163 172
24. A.N. Kong, R. Yu, V. Hebbar, C. Chen, E. Owuor, R. Hu, R. Ee, and S. Mandlekar Signal transduction events elicited by cancer prevention compounds Mutat. Res. 480-481 2001 231 241
25. G. Shen, V. Hebbar, S.S. Nair, C. Xu, W. Li, W. Lin, Y.S. Keum, J. Han, M.A. Gallo, A.N. Kong, Regulation of Nrf2 transactivation domain activity: the differential effects of mitogen-activated protein kinase cascades and synergistic stimulation effect of Raf and CREB binding protein, J. Biol. Chem. 279 (2004) 23052-23060.
26. R.M. Niles, M. McFarland, M.B. Weimer, A. Redkar, Y.M. Fu, and G.G. Meadows Resveratrol is a potent inducer of apoptosis in human melanoma cells Cancer Lett. 190 2003 157 163
27. Q.B. She, A.M. Bode, W.Y. Ma, N.Y. Chen, and Z. Dong Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase Cancer Res. 61 2001 1604 1610
28. Q.B. She, C. Huang, Y. Zhang, and Z. Dong Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis Mol. Carcinog. 33 2002 244 250
29. E. Pozo-Guisado, M.J. Lorenzo-Benayas, and P.M. Fernandez-Salguero Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation Int. J. Cancer 109 2004 167 173
30. B.A. Narayanan, N.K. Narayanan, G.G. Re, and D.W. Nixon Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets Int. J. Cancer 104 2003 204 212
31. Y.-J. Surh Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances Mutat. Res. 428 1999 305 327
32. F. Afaq, V.M. Adhami, and N. Ahmad Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice Toxicol. Appl. Pharmacol. 186 2003 28 37
33. K. Subbaramaiah, W.J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J.M. Pezzuto, and A.J. Dannenberg Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells J. Biol. Chem. 273 1998 21875 21882
34. K. Subbaramaiah, P. Michaluart, W.J. Chung, T. Tanabe, N. Telang, and A.J. Dannenberg Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells Ann. NY Acad. Sci. 889 1999 214 223
35. A.R. Martin, I. Villegas, C. La Casa, and C.A. de la Lastra Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats Biochem. Pharmacol. 67 2004 1399 1410
36. J. Martinez, and J.J. Moreno Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production Biochem. Pharmacol. 59 2000 865 870
37. M. Jang, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol Drugs Exp. Clin. Res. 25 1999 65 77
38. A. Murakami, K. Matsumoto, K. Koshimizu, and H. Ohigashi Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IκB degradation in RAW264.7 macrophages Cancer Lett. 195 2003 17 25
39. H. Matsuda, T. Kageura, T. Morikawa, I. Toguchida, S. Harima, and M. Yoshikawa Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages Bioorg. Med. Chem. Lett. 10 2000 323 327
40. J.K. Kundu, K.-S. Chun, S.O. Kim, Y.-J. Surh, Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets, Biofactors, in press.
41. M. Nielsen, R.J. Ruch, and O. Vang Resveratrol reverses tumor-promoter-induced inhibition of gap-junctional intercellular communication Biochem. Biophys. Res. Commun. 275 2000 804 809
42. Z. Dong Molecular mechanism of the chemopreventive effect of resveratrol Mutat. Res. 523-524 2003 145 150
43. Y.-J. Surh, Y.-J. Hurh, J.Y. Kang, E. Lee, G. Kong, and S.J. Lee Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells Cancer Lett. 140 1999 1 10
44. M.V. Clement, J.L. Hirpara, S.H. Chawdhury, and S. Pervaiz Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 92 1998 996 1002
45. J. Dorrie, H. Gerauer, Y. Wachter, and S.J. Zunino Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells Cancer Res. 61 2001 4731 4739
46. D. Delmas, C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, and E. Solary Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells J. Biol. Chem. 278 2003 41482 41490
47. C. Huang, W.Y. Ma, A. Goranson, and Z. Dong Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway Carcinogenesis 20 1999 237 242
48. H.Y. Lin, A. Shih, F.B. Davis, H.Y. Tang, L.J. Martino, J.A. Bennett, and P.J. Davis Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line J. Urol. 168 2002 748 755
49. V. Cardile, C. Scifo, A. Russo, M. Falsaperla, G. Morgia, M. Motta, M. Renis, E. Imbriani, and G. Silvestre Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer Anticancer Res. 23 2003 4921 4926
50. P.L. Kuo, L.C. Chiang, and C.C. Lin Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells Life Sci. 72 2002 23 34
51. J.W. Park, Y.J. Choi, S.I. Suh, W.K. Baek, M.H. Suh, I.N. Jin, D.S. Min, J.H. Woo, J.S. Chang, A. Passaniti, Y.H. Lee, and T.K. Kwon Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity Carcinogenesis 22 2001 1633 1639
52. H.B. Zhou, Y. Yan, Y.N. Sun, and J.R. Zhu Resveratrol induces apoptosis in human esophageal carcinoma cells World J. Gastroenterol. 9 2003 408 411
53. Y.A. Kim, B.T. Choi, Y.T. Lee, D.I. Park, S.H. Rhee, K.Y. Park, and Y.H. Choi Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells Oncol. Rep. 11 2004 441 446
54. M. Mahyar-Roemer, A. Katsen, P. Mestres, and K. Roemer Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse Int. J. Cancer 94 2001 615 622
55. M. Mahyar-Roemer, H. Kohler, and K. Roemer Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells BMC Cancer 2 2002 27
56. K.A. Ahmad, M.V. Clement, and S. Pervaiz Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis Ann. NY Acad. Sci. 1010 2003 365 373
57. K.A. Ahmad, M.V. Clement, I.M. Hanif, and S. Pervaiz Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution Cancer Res. 64 2004 1452 1459
58. M. Fontecave, M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet Resveratrol, a remarkable inhibitor of ribonucleotide reductase FEBS Lett. 421 1998 277 279
59. N. Ahmad, V.M. Adhami, F. Afaq, D.K. Feyes, and H. Mukhtar Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells Clin. Cancer Res. 7 2001 1466 1473
60. V.M. Adhami, F. Afaq, and N. Ahmad Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells Biochem. Biophys. Res. Commun. 288 2001 579 585
61. L. Yu, Z.J. Sun, S.L. Wu, and C.E. Pan Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer World J. Gastroenterol. 9 2003 2341 2343
62. S. Reagan-Shaw, F. Afaq, M.H. Aziz, N. Ahmad, Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin, Oncogene 23 (2004) 5151-5160.
63. A.K. Joe, H. Liu, M. Suzui, M.E. Vural, D. Xiao, and I.B. Weinstein Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin. Cancer Res. 8 2002 893 903
64. F. Wolter, B. Akoglu, A. Clausnitzer, and J. Stein Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines J. Nutr. 131 2001 2197 2203
65. Y.A. Kim, S.H. Rhee, K.Y. Park, and Y.H. Choi Antiproliferative effect of resveratrol in human prostate carcinoma cells J. Med. Food. 6 2003 273 280
66. M. Larrosa, F.A. Tomas-Barberan, and J.C. Espin Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells J. Agric. Food Chem. 51 2003 4576 4584
67. M. Karin How NF-κB is activated: the role of the IκB kinase (IKK) complex Oncogene 18 1999 6867 6874
68. E. Shaulian, and M. Karin AP-1 as a regulator of cell life and death Nature Cell Biol. 4 2002 E131 E136
69. T.G. Canty Jr., E.M. Boyle Jr., A. Farr, E.N. Morgan, E.D. Verrier, and T.H. Pohlman Oxidative stress induces NF-κB nuclear translocation without degradation of IκBα Circulation 100 1999 II361 II364
70. B.C. Wong, X. Jiang, X.M. Fan, M.C. Lin, S.H. Jiang, S.K. Lam, and H.F. Kung Suppression of RelA/p65 nuclear translocation independent of IκBα degradation by cyclooxygenase-2 inhibitor in gastric cancer Oncogene 22 2003 1189 1197
71. V. Imbert, R.A. Rupec, A. Livolsi, H.L. Pahl, E.B. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P.A. Baeuerle, and J.F. Peyron Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα Cell 86 1996 787 798
72. A.C. Koong, E.Y. Chen, N.F. Mivechi, N.C. Denko, P. Stambrook, and A.J. Giaccia Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2) Cancer Res. 54 1994 5273 5279
73. Y. Takada, A. Mukhopadhyay, G.C. Kundu, G.H. Mahabeleshwar, S. Singh, and B.B. Aggarwal Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase J. Biol. Chem. 278 2003 24233 24241
74. P. Angel, and M. Karin The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim. Biophys. Acta 1072 1991 129 157
75. R. Wisdom AP-1: one switch for many signals Exp. Cell Res. 253 1999 180 185
76. M.R. Young, H.S. Yang, and N.H. Colburn Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4 Trends Mol. Med. 9 2003 36 41
77. P. Angel, M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor Cell 49 1987 729 739
78. T.D. Halazonetis, K. Georgopoulos, M.E. Greenberg, and P. Leder c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities Cell 55 1988 917 924
79. T. Kouzarides, and E. Ziff The role of the leucine zipper in the fos-jun interaction Nature 336 1988 646 651
80. M. Karin The regulation of AP-1 activity by mitogen-activated protein kinases J. Biol. Chem. 270 1995 16483 16486
81. A.J. Whitmarsh, and R.J. Davis Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways J. Mol. Med. 74 1996 589 607
82. T. Deng, and M. Karin c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK Nature 371 1994 171 175
83. F.R. Greten, and M. Karin The IKK/NF-κB activation pathway - a target for prevention and treatment of cancer Cancer Lett. 206 2004 193 199
84. F. Chen, V. Castranova, and X. Shi New insights into the role of nuclear factor-κB in cell growth regulation Am. J. Pathol. 159 2001 387 397
85. E. Shaulian, and M. Karin AP-1 in cell proliferation and survival Oncogene 20 2001 2390 2400
86. S.H. Tsai, S.Y. Lin-Shiau, and J.K. Lin Suppression of nitric oxide synthase and the down-regulation of the activation of NF-κB in macrophages by resveratrol Br. J. Pharmacol. 126 1999 673 680
87. D.I. Cho, N.Y. Koo, W.J. Chung, T.S. Kim, S.Y. Ryu, S.Y. Im, and K.M. Kim Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanism of action Life Sci. 71 2002 2071 2082
88. T.L. Wadsworth, and D.R. Koop Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages Biochem. Pharmacol. 57 1999 941 949
89. M. Holmes-McNary, and A.S. Baldwin Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase Cancer Res. 60 2000 3477 3483
90. U.R. Pendurthi, F. Meng, N. Mackman, and L.V. Rao Mechanism of resveratrol-mediated suppression of tissue factor gene expression Thromb. Haemost. 87 2002 155 162
91. Z. Estrov, S. Shishodia, S. Faderl, D. Harris, Q. Van, H.M. Kantarjian, M. Talpaz, and B.B. Aggarwal Resveratrol blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells Blood 102 2003 987 995
92. S.S. Leonard, C. Xia, B.H. Jiang, B. Stinefelt, H. Klandorf, G.K. Harris, and X. Shi Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses Biochem. Biophys. Res. Commun. 309 2003 1017 1026
93. W.S. Jeong, I.W. Kim, R. Hu, and A.N. Kong Modulatory properties of various natural chemopreventive agents on the activation of NF-κB signaling pathway Pharm. Res. 21 2004 661 670
94. V.M. Adhami, F. Afaq, and N. Ahmad Suppression of ultraviolet B exposure-mediated activation of NF-κB in normal human keratinocytes by resveratrol Neoplasia 5 2003 74 82
95. S.K. Manna, A. Mukhopadhyay, and B.B. Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation J. Immunol. 164 2000 6509 6519
96. R. Yu, V. Hebbar, D.W. Kim, S. Mandlekar, J.M. Pezzuto, and A.N. Kong Resveratrol inhibits phorbol ester and UV-induced activator protein-1 activation by interfering with mitogen-activated protein kinase pathways Mol. Pharmacol. 60 2001 217 224
97. W.S. Jeong, I.W. Kim, R. Hu, and A.N. Kong Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line Pharm. Res. 21 2004 649 660
98. H. Asou, K. Koshizuka, T. Kyo, N. Takata, N. Kamada, and H.P. Koeffier Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias Int. J. Hematol. 75 2002 528 533
99. F. Shen, S.J. Chen, X.J. Dong, H. Zhong, Y.T. Li, and G.F. Cheng Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells J. Asian Nat. Prod. Res. 5 2003 151 157
100. Y.T. Li, F. Shen, B.H. Liu, and G.F. Cheng Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells Acta Pharmacol. Sin. 24 2003 1167 1171
101. F. Wolter, L. Turchanowa, and J. Stein Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos Carcinogenesis 24 2003 469 474
102. A. Shih, F.B. Davis, H.Y. Lin, and P.J. Davis Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism J. Clin. Endocrinol. Metab. 87 2002 1223 1232
103. M. Mouria, A.S. Gukovskaya, Y. Jung, P. Buechler, O.J. Hines, H.A. Reber, and S.J. Pandol Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis Int. J. Cancer 98 2002 761 769
104. V. Roman, C. Billard, C. Kern, H. Ferry-Dumazet, J.C. Izard, R. Mohammad, D.M. Mossalayi, and J.P. Kolb Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia Br. J. Haematol. 117 2002 842 851
105. K.P. Bhat, and J.M. Pezzuto Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells Cancer Res. 61 2001 6137 6144
106. Y. Kimura, and H. Okuda Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice J. Nutr. 131 2001 1844 1849